AdvanSix ASIX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Sales by Product | ||||||
| Caprolactam | $67.77M+5.3% | $64.38M-12.0% | $73.14M+10.1% | $66.42M-1.5% | $67.43M+17.9% | |
| Chemical Intermediates | $107.31M+15.7% | $92.78M+10.9% | $83.65M-22.1% | $107.33M+14.5% | $93.75M-8.2% | |
| Nylon | $88.47M+40.9% | $62.78M-20.6% | $79.03M-0.6% | $79.5M-10.0% | $88.37M+31.5% | |
| Plant Nutrients | $140.64M+0.4% | $140.02M+1.0% | $138.66M-11.6% | $156.77M+22.2% | $128.24M+25.0% | |
| Concentration risk percentage by Product | ||||||
| Caprolactam | 17%— | —— | 20%+4.0pp | 16%-2.0pp | 18%— | |
| Chemical Intermediates | 26%— | —— | 22%-4.0pp | 26%+1.0pp | 25%+24.0pp | |
| Nylon | 22%— | —— | 21%+1.0pp | 20%-3.0pp | 23%— | |
| Plant Nutrients | 35%+34.0pp | 1%-36.0pp | 37%-1.0pp | 38%+4.0pp | 34%— | |
| Sales by Geography | ||||||
| International | $68.19M+28.5% | $53.06M+4.6% | $50.73M-1.2% | $51.35M-10.5% | $57.34M+13.7% | |
| United States | $336M+9.5% | $306.89M-5.2% | $323.75M-9.7% | $358.67M+11.9% | $320.45M+15.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AdvanSix break its business down?
- AdvanSix (ASIX) reports sales by product across 4 parts — Caprolactam, Chemical Intermediates, Nylon and Plant Nutrients. Each is extracted from the segment footnotes and tracked over time.
- Where does AdvanSix's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AdvanSix's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
